Reference health
The inhibition of epidermal growth factor receptor signaling by hexagonal selenium nanoparticles modified by SiRNA
18/18 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 18 checked references that resolve
resolves10.1038/nbt0402-370
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors
resolves10.1158/1078-0432.CCR-12-2246
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with
<i>EGFR</i>
-Mutant Lung Cancers
resolves10.1038/nature11156
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
resolves10.1074/jbc.M114.575464
Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
resolves10.1002/dvdy.24209
<i>carbamoyl‐phosphate synthetase 2</i>, <i>aspartate transcarbamylase</i>, and <i>dihydroorotase</i> (<i>cad</i>) regulates Notch signaling and vascular development in zebrafish
resolves10.1016/S0092-8674(02)00966-2
Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor
resolves10.1016/j.msec.2014.04.018
In vitro and in vivo evaluation of a new nanocomposite, containing high density polyethylene, tricalcium phosphate, hydroxyapatite, and magnesium oxide nanoparticles
resolves10.3109/01480545.2013.878952
The cytotoxicity of silver nanoparticles coated with different free fatty acids on the Balb/c macrophages: an<i>in vitro</i>study
resolves10.1007/s10549-005-9011-0
EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization
resolves10.1016/j.ccell.2015.05.012
The Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic
resolves10.1200/JCO.2014.58.1736
Impact of Specific Epidermal Growth Factor Receptor (<i>EGFR</i>) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in <i>EGFR</i>-Mutant Lung Cancer: A Meta-Analysis
The 6 references without a DOI — listed, not checked
no DOI — not checkedLeighl NB, Rekhtman N, Biermann WA, Huang J, Mino-Kenudson M, Ramalingam SS et al. Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American society of clinical oncology endorsement of the college of american pathologists/international society for the study of lung cancer/association of molecular pathologists guideline. Journal of Clinical Oncology 2014: JCO 2014; 57: 3055.
no DOI — not checkedGuix M, Faber AC, Wang SE, Olivares MG, Song Y, Qu S et al. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. The Journal of clinical investigation 2008; 118: 2609–2619.
no DOI — not checkedHarris RC, Chung E, Coffey RJ . EGF receptor ligands The EGF receptor family biologic mechanisms and role in cancer. Elsevier: California, 2004: 3–14.
no DOI — not checkedHuang S-M, Li J, Armstrong EA, Harari PM . Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer research 2002; 62: 4300–4306.
no DOI — not checkedBarkhordari A, Barzegar S, Hekmatimoghaddam H, Jebali A, Moghadam SR, Khanjani N . The toxic effects of silver nanoparticles on blood mononuclear cells. The international journal of occupational and environmental medicine 2014; 5: 394–164-8.
no DOI — not checkedRusnak DW, Affleck K, Cockerill SG, Stubberfield C, Harris R, Page M et al. The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors potential therapy for cancer. Cancer Research 2001; 61: 7196–7203.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1038/cgt.2016.38"><img src="https://citestamp.com/citestamped/10.1038/cgt.2016.38/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1038/cgt.2016.38)